Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
epilepsy [2018/11/18 10:59]
sflitman [Epilepsy and Seizure Disorders]
epilepsy [2019/07/21 11:50] (current)
sflitman [Epilepsy and Seizure Disorders]
Line 9: Line 9:
 ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^ ^ Condition(s) ^ Type of Drug ^ Phase ^ Add-On ^ Placebo ^ Duration ^ Open Label Extension ^
 | Partial Seizures |  Novel oral agent  |  II  |  Yes  |  20%  |  20 weeks  |  To market ​ | | Partial Seizures |  Novel oral agent  |  II  |  Yes  |  20%  |  20 weeks  |  To market ​ |
-| Partial Seizures |  ​Intravenous Natalizumab ​ ​| ​ II  |  Yes  |  ​50%  |  ​6 months ​ ​| ​  6 months ​ |+| Partial Seizures |  ​Novel potassium blocker ​ ​| ​ II  |  Yes  |  ​20%  |  ​20 weeks  ​| ​ To market ​ |
  
  
Print/export
QR Code
QR Code epilepsy (generated for current page)